Clinical Trial: Clinical Evaluation of Dual-Plane Technique PN-Based Treatment for Horizontal Neck Lines Using DNA Fragment Opmizing Technology Polynucleotide (DOT PN)

U.S., Nov. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07912879) titled 'Clinical Evaluation of Dual-Plane Technique PN-Based Treatment for Horizontal Neck Lines Using DNA Fragment Opmizing Technology Polynucleotide (DOT PN)' on Oct. 28.

Brief Summary: The goal of this clinical study is to evaluate changes in the appearance of horizontal neck lines after treatment with DOT PN (Rejuran S), a polynucleotide-based injectable medical device, administered using a dual-plane injection technique in adults aged 25 to 65 years with mild to moderate horizontal neck lines.

The main question it aims to answer is:

- What is the mean change in horizontal neck wrinkle depth from the start of the study (Week 0) to Week...